Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|May 5, 2024
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 23, 2019
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium ProgramLing Li, Ruifang Sun, Yi Miao, et al.
Blood Advances|June 17, 2026
Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphomaZijun Y Xu-Monette, Chang Wang, Dehong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countriesChi Young Ok, Ling Li, Zijun Y Xu-Monette, et al.
Eclinicalmedicine|April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatmentLuca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2015
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapyZhiyu Liu, Zijun Y Xu-Monette, Xin Cao, et al.
Lancet (London, England)|May 14, 2026
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL NetworkMartin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
American Journal of Hematology|April 16, 2026
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International ExperienceBruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, et al.
Hematological Oncology|October 20, 2022
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohortMichele Merli, Isacco Ferrarini, Francesco Merli, et al.
Cancer Immunology Research|February 13, 2019
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCLZiju Y Xu-Monette, Min Xiao, Qingyan Au, et al.
Pageof 17